Objectives: To present a rare case of primary laryngeal aspergillosis manifesting with hoarseness in a seemingly healthy, immunocompetent, postpartum patient and discuss the probable contributing factors leading to this unusual disease process.
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Disclosures: The authors signed disclosures that there are no financial or other (including personal) relationships, intellectual passion, political or religious beliefs, and institutional affiliations that might lead to a conflict of interest Poster Presentation, 2013 American Academy of Otolaryngology -Head and Neck Surgery Foundation Annual Meeting and OTO EXPO, Vancouver, B.C., Canada, September 29-October 2, 2013. and the cough, colds and fever resolved, but her hoarseness persisted. She consulted an otorhinolaryngologist after discharge and was started on Cefuroxime 500 mg and Loratadine 5mg + Betamethasone 500mcg twelve-hourly, Esomeprazole 40 mg and Prednisone 50 mg once daily for two weeks with no improvement of her hoarseness. She consulted in our institution, where videolaryngoscopy revealed a creamy exophytic mass overlying both vocal folds. (Figure 1 ) There was good movement of both true vocal folds but incomplete closure due to the lesion. Chest x-ray, complete blood count, serum chemistries and electrolytes were all normal. She underwent direct laryngoscopy with excision of TVF mass under general anesthesia. Tissue sections stained with hematoxylin and eosin revealed acutely angled, dichotomously branching, septated hyphae characteristic of Aspergillus. (Figure 2 ) An HIV screen was negative, and neck and chest CT scans were normal. With a diagnosis of laryngeal aspergillosis, she was treated with oral Voriconazole 400 mg once daily for a month. The patient's voice gradually improved with the anti fungal medications, and follow up videolaryngoscopy eventually revealed normal findings. (Figures 3, 4) 
DISCUSSION
Aspergillus is an inherently non pathogenic or weakly pathogenic fungus that produces a group of opportunistic infections. 3 It afflicts mostly immunocompromised patients and manifests mainly as a primary pulmonary disease with secondary systemic involvement. 4 It is due to this nature of the organism that there have been only a few cases of primary laryngeal aspergillosis in immuno-compromised patients 5 and even less in immuno-competent patients. 1 According to Shohami and Levitz, "Aspergillus is a highly aerobic mold with several hundred mold species with worldwide distribution. It is a saprophyte that draws nutrients from soil and vegetation. Spores are easily aerosolized and humans inhale and ingest hundreds of conidia on a daily basis. " 6 International and local data has shown that the most frequently isolated airborne mold is Aspergillus. 7, 8 In an immune competent host, ingested or inhaled spores are rapidly cleared by the innate immune response. 6 Resident and monocytederived macrophages ingest and kill conidia, preventing transition into the invasive hyphal form. 
CASE REPORTS
The disease form of Aspergillosis most commonly involves the lungs and the tracheo-bronchial tree with subsequent systemic dissemination when host immunity deteriorates. 2, 4 Because of this usual clinical presentation, the fungus has been greatly regarded as an opportunistic infection. It has been reported to have had secondary spread to almost all parts of the human body, including the larynx, 9 but the most frequent otolaryngologic sites colonized by Aspergillus are the external auditory canal and the paranasal sinuses. Aspergillus is weakly pathogenic and is by nature an opportunist, it is worthwhile to look closely into cases such as this, involving healthy individuals and localizing only in the larynx. 8 Previous case reports have dwelled upon the possible etiologic and contributing factors to the development of the disease in immunocompetent patients. 2, 4, 5, 6, 9 One factor that has been cited is the use of corticosteroids, particularly inhaled corticosteroids owing to the substantial proportion of particles deposited in the larynx. 10 Corticosteroids significantly affect the patient's response to the Aspergillus conidia by inhibiting production of reactive oxidant intermediates (a component of intracellular killing) and by depressing neutrophil and macrophage function. 2 Another potentially contributory factor is the use of broad spectrum antibiotics that could alter local bacterial flora and disturb the ecological balance between bacteria and fungi, allowing the overgrowth of Aspergillus. Several cases of invasive Aspergillosis have been observed in patients receiving multiple antibiotics.
11
Factors that disrupt the normal mucosal integrity of the larynx have also been implicated. An intact epithelial barrier is an esential protective component. Vocal abuse resulting in disruption of true vocal fold mucosa and vocal fold cysts have been cited as potential aggravating factors. 12, 13 Several of these factors were present in our patient, and may explain how she developed laryngeal Aspergillosis. Although she had no history of vocal abuse, the episodes of forceful coughing could have created areas of disruption or injury in the laryngeal mucosa. She was then given broad spectrum antibiotics and oral steroids, which have all been implicated as possible factors in the development of laryngeal Aspergillosis. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Whether her post partum status (marked by decreased natural killer cell function) 14 was contributory may be a matter for conjecture, as natural killer cells are integral to the innate immune response and play an important role in the body's defense against fungi. All these factors coincidentally occuring simultaneously may have lead to the development of this rare form of primary laryngeal aspergillosis.
To the best of our knowledge, this is the twenty-second reported case of primary laryngeal aspergillosis occurring in an immunocompetent patient in the English literature, the first occurring during the postpartum period, and the first in the Philippines.
The clinical presentation of laryngeal aspergillosis can be very nonspecific and should not be disregarded merely on the basis of immune competence. It should be considered, together with other host and environmental factors (fungal exposure, corticosteroid and antibiotic use, vocal fold injury, recuperative / postpartum states) when a patient responds poorly to conventional treatment. There is a need for quick and accurate diagnosis as the disease responds quite rapidly with appropriate anti fungal medications.
